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A pilot study to determine the normal haematological 
indices for young Malawian adults in Blantyre, Malawi
Abstract
Background
Reference ranges for haematological and other laboratory tests in most 
African countries are based on populations in Europe and America and, 
because of  environmental and genetic factors, these may not accurately 
reflect the normal reference ranges in African populations.
Aim
To determine the distribution of  haematological parameters in healthy 
individuals residing in Blantyre, Malawi. We also examined the effect of  
sociodemographic and nutritional factors on the haematological variables.
Methods
We conducted a proof-of-concept cross-sectional study, involving 105 
healthy blood donors at Malawi Blood Transfusion Service in Blantyre. 
Eligible participants were HIV-negative males and females, aged 19 to 35 
years, who did not have any evidence of  acute or chronic illness, or blood-
borne infection. We performed the haematological tests at the Malawi-
Liverpool Wellcome Trust laboratory in Blantyre, and the screening tests 
at Malawi Blood Transfusion Service laboratories.
Results
Out of  170 consenting healthy volunteers, haematological results were 
available for 105 participants. The proportions of  results which were 
below the lower limit of  the manufacturer’s reference ranges were 
35.2% (37/105) for haemoglobin, 15.2% (16/105) for neutrophils, 
23.8% (25/105) for eosinophils, and 88.6 % (93/105) for basophils. 
The proportions of  results that were above the upper limit of  the 
manufacturer’s reference ranges were 9.5% (10/105) for platelets and 
12.4% (13/105) for monocytes. We also observed that the mean leucocyte 
and basophil counts were significantly higher in males than females (p = 
0.042 and p = 0.015, respectively). There were no statistically significant 
differences in haematological results observed among different ethnic, 
age, and body mass index groups.
Conclusions 
Over half  of  otherwise healthy study participants had at least one abnormal 
haematological result, using previously established foreign standards. 
More detailed studies are needed to establish locally relevant normal 
ranges for different age groups and other demographic characteristics 
of  the Malawian population. This will lead to accurate interpretation of  
laboratory results.
Introduction
In most African countries, including Malawi, normal 
reference ranges for laboratory variables used in clinical 
trial and clinical care are obtained from European and 
North American populations.1 However, there are marked 
differences in values of  haematological variables between 
normal African populations and those of  North America 
and Europe.2 For example, healthy African populations are 
reported to have lower haemoglobin (Hb) levels, red blood 
cell (RBC) counts, haematocrits (HCT), mean corpuscular 
volumes (MCV), and platelet and neutrophil counts, and 
higher monocyte and eosinophil levels than their Western 
counterparts.3 These differences present challenges in 
interpreting laboratory results from African countries based 
on reference ranges developed from other populations. 
Furthermore, there are variations in the variables among 
different African ethnic groups.4,5
Several factors may account for differences in haematological 
variables. These include genetics, nutritional status, age, and 
environmental factors. Of  all factors, genetic characteristics 
of  populations are believed to account for the majority of  
the variations in haematological variables.6,7 For example, 
haematological values for Caucasian adults have been found 
to be higher than for adults of  both African8 and Afro-
Caribbean9-11 origin. Even within Africa, there are marked 
variations in haematological variables among various healthy 
subpopulations. A previous study in western Kenya found 
that Hb and MCV values for healthy young adults and 
adolescents were higher than those reported from another 
study in the highlands west of  the Kenyan Rift Valley,2 but 
slightly lower than those derived from Ethiopia, Kampala in 
Uganda, and Mbeya in Tanzania.12-14
Within specific subpopulations, age accounts for most of  
the variation among haematological variables in healthy 
individuals. Previous studies in Uganda and other countries 
in Africa8,12,15,16 found significant differences in Hb, HCT, and 
RBC values between adolescent and adult males. Although 
age is an important determinant of  haematological values 
within populations, significant differences still remain among 
different populations within the same age groups. For 
example, healthy under-five children from Africa have lower 
values of  haematological variables than children of  the same 
age from Western populations.12-14,17 It has, therefore, been 
recommended that each population must establish its own 
“normal” reference values for use in clinical assessments.18
Although several studies in Africa have attempted to 
establish normal haematological reference ranges for their 
local populations, key limitations have often been identified. 
For example, one study in Mozambique used finger prick 
instead of  venous samples17; another study in Kenya did not 
screen the participants for malaria, hepatitis, and syphilis8; 
while other studies did not consider the body mass indexes 
(BMI) of  study participants. These factors could have 
affected values of  haematological variables; therefore, the 
utility of  reference ranges from these studies may be limited.
To date there have been few attempts (most notably in 
paediatrics) to define normal haematological indices for 
Malawians, despite the significant number of  clinical 
trials conducted in the country. Thus, we conducted a 
study to determine the distribution (median and range) of  
haematological parameters in healthy, HIV-negative young 
adults in Blantyre, Malawi. We also assessed the effect 
of  sociodemographic and nutritional factors on these 
haematological parameters. 
Materials and methods
Study design and setting
From mid-July to mid-September 2013, we conducted a 
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cross-sectional study involving healthy blood donors at the 
static site of  the Malawi Blood Transfusion Service (MBTS) 
in Blantyre in  southern Malawi. As one of  Malawi’s major 
commercial cities, Blantyre is home to people originating 
from many districts in Malawi. 
Study population
The targeted population consisted of  young males and 
females who were registered as new or repeat blood donors 
at the MBTS. To be eligible for the study, the blood donors 
had to be aged between 19 and 35 years, residents of  
Blantyre District, and give consent to participate in the study. 
Participants who met any of  the following criteria were 
excluded from the study: those with detectable blood-borne 
infections such as malaria, HIV, syphilis, or hepatitis; females 
who were menstruating, pregnant, or lactating; those with 
any evidence of  acute or chronic illness at the time of  the 
study or in the preceding 3 months; those taking medications 
for any medical condition; those who smoked tobacco or 
consumed alcohol or had a current or past history of  using 
illicit drugs; those who had experienced significant blood 
loss, from any cause (for example, surgery or trauma) within 
the preceding three months; those who had donated blood 
within the preceding three months; or those who had received 
a blood transfusion within the preceding 12 months.
Sample size
The National Committee for Clinical Laboratory Services 
(NCCL) recommends that studies to establish normal 
reference ranges should have a minimum sample size of  120 
subjects for each demographic subset of  study participants.19 
According to this guideline, at least 240 participants (120 
males and 120 females) should have been enrolled into the 
study. Budgetary constraints, however, resulted in a target of  
60 males and 60 females.
Data collection procedures
Ethical approval for the study was obtained from the 
University of  Malawi’s College of  Medicine Research and 
Ethics Committee (COMREC) prior to data collection. 
Before seeking informed consent we provided a study 
leaflet to all potential blood donors in order to provide an 
overview of  the study objectives, rationale, procedures, risks, 
and benefits. Thereafter, MBTS staff  conducted a routine 
medical assessment of  the blood donors as per their normal 
procedures and completed standard forms, which captured 
some of  the items in the eligibility criteria. The completed 
standard forms were reviewed by the principal investigator to 
exclude those who did not meet some of  the study eligibility 
criteria. Informed consent was sought from those who met 
all of  the eligibility criteria captured during the standard 
MBTS assessment. 
After consent was granted, study team members 
administered a study-specific questionnaire to assess 
whether the consenting individuals satisfied the eligibility 
criteria additional to those that were routinely captured on 
the standard MBTS forms. Once a consenting participant 
had satisfied the eligibility criteria, his or her venous blood 
was collected into a blood collection bag, as per the standard 
MBTS blood collection procedure. Thereafter, blood left 
over from the tube connecting the cannula and the blood 
bag was immediately transferred into blood collection tubes 
as follows: 3 mL into a K2 EDTA tube, 5 mL into another 
K2 EDTA tube and 3 mL into a plain vacutainer tube. The 5 
mL of  blood collected into the plain and K2 EDTA tube was 
used for blood screening tests at MBTS, while the 3 mL tube 
was used for haematological tests at the Malawi-Liverpool 
Wellcome Trust (MLW) laboratory in Blantyre.
Laboratory analyses
Haematological analysis
Approximately 1 mL of  the whole blood in the 3 mL EDTA 
tube was used to perform absolute white blood cell (WBC) 
counts (including differential counts), RBC counts (along 
with associated variables, such as Hb, HCT, MCV, and mean 
corpuscular haemoglobin [MCH]), and platelets counts. A 
Beckman Coulter HmX haematology analyzer was used to 
perform these analyses. Clotted or turbid blood samples, 
and those with signs of  severe lipaemia were not analyzed 
because they are known produce unreliable and inaccurate 
haematological variables.
Screening tests
As part of  the standard procedure at MBTS, 5 mL of  blood 
collected in plain and K2 EDTA tubes were screened for 
HIV, syphilis, and hepatitis using enzyme immunoassays 
(EIAs) or haemagglutination (HA) and particle agglutination 
(PA) assays, as appropriate. In addition, thick blood slides 
were prepared, stained with Field’s stain and examined for 
malaria parasites. The study used results from the standard 
screening tests to exclude all participants who did not meet 
the laboratory-based eligibility criteria.
Quality control protocols
As part of  the standard procedure at MBTS, 5 mL of  
blood coThe haematology tests were performed at MLW 
laboratory, a reputable and international-standard laboratory, 
which has been performing laboratory assays for a large 
number of  clinical trials conducted at Queen Elizabeth 
Central Hospital for over 20 years. The laboratory has 
active External Quality Assessment (EQA) registration with 
internationally reputable quality control agencies such as 
the United Kingdom National External Quality Assessment 
Service (UK NEQAS, for haematology assays). In addition 
to the EQA system, the laboratory performs internal quality 
assurance tests by running known standards at the start of  
each day and weekly, as well as running reproducibility tests 
before testing samples.
Data management and analysis
Sociodemographic and clinical data were collected in a case 
report forms (CRFs) while laboratory data were recorded 
in excel spreadsheets. The lead investigators cross checked 
each CRF and spreadsheet to detect any transcription errors. 
Thereafter, data were double-entered into a Microsoft Access 
database, which was imported into Statistical Package for 
Social Science (SPSS) software (version 16.0) for analyses. 
Data analyses focused on performing descriptive statistics. 
We also generated a measures of  central tendency (median) 
and spread (range). We compared our data against reference 
limits from the machine used, which are based on a European 
population. The severity of  “abnormalities” was classified 
using the Division of  AIDS (DAIDS) criteria.20 We used the 
t-test to compare the distribution of  continuous variables 
between gender, age, ethnic and BMI categories. A two-sided 
p-value of  0.05 was considered significant. 
Results
Characteristics of study participants
A total of  170 blood donors were screened for their eligibility 
to participate in the study. Fifty (29.4%) of  the donors were 
excluded based on the defined exclusion criteria, which aimed 
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at eliminating participants with known medical conditions, 
or who were involved in any incident or activity which 
would likely affect their haematological variables. Blood 
samples were collected from the remaining 120 individuals. 
Of  the 120 samples collected, two were excluded because 
of  of  clotting and 13 were excluded because of  positive 
screening tests results for blood-borne infections such as 
malaria, HIV, viral hepatitis, and syphilis. The remaining 105 
participants’ samples were included in the study for analysis. 
Table 1 shows the baseline characteristics of  the recruited 
study participants. The study participants were young adults 
(median age = 25 years), and over one-third of  them were 
students. The participants were predominantly male and 
over one-third belonged to the Lomwe tribe. The BMIs of  
most study participants was within the normal range, as per 
World Health Organization (WHO) criteria.
Discussion
In clinical practice, haematologic tests are necessary and 
important in diagnosing and monitoring diseases. In clinical 
trials, the tests are used to assess eligibility of  subjects to 
participate in trials and for monitoring safety of  medical 
interventions over time. In this study, we found that values of  
haematological variables for a significant number of  otherwise 
normal Malawians had values outside the haematology 
machine reference ranges, suggesting abnormalities. 
According to the DAIDS criteria, most of  the abnormal 
values were graded as mild (grade 1) or moderate (grade 2) 
in severity. However, some subjects had thrombocytopenia 
and neutropenia that was graded as severe or potentially life-
threatening. Based on our haematological reference ranges, 
at least one-third of  our healthy study participants would 
have been reported as having AEs.
The specific abnormal haematological variables found in 
this study are consistent with previous studies conducted 
in other African countries. A similar study done in 
western Kenya17 also found eosinophilia, neutropenia, 
and leucopoenia in otherwise normal individuals. In 
the Kenyan study, abnormal values were also graded as 
severe and potentially life-threatening. Likewise, studies 
in Uganda, Tanzania and Ethiopia8,13,14 found lower Hb 
concentrations among African subjects compared to North 
American and European reference ranges and controls. In 
addition, other investigations conducted in Uganda, Kenya, 
Ghana, and South Africa2,14,21,22 showed higher eosinophil 
counts in African subjects compared with their North 
American counterparts. Furthermore, research done  in 
Uganda, Ethiopia, Zambia, and Nigeria3,5,13,14 revealed high 
prevalences of  thrombocytopenia in African populations, 
based on reference ranges from Western populations.
Characteristic* N*=*105* *
Sex*(%)* * * *
* Male* 96* (91.4)* *
* Female* 9* (8.6)*
Ethnic*group*(%)* * * *
* Yao* 18* (17.1)*
* Ngoni* 18* (17.1)*
* Lomwe* 38* (36.2)*
* Others* 31* (29.5)*
Occupation*(%)* * * *
* Manual*work* 34* (32.4)*
* NonLmanual*work* 26* (24.8)*
* Not*working* 7* (6.7)*


















Table 1: Demographic characteristics of the participants
Haematological parameters for enrolled study 
participants
Almost all variables generated some values that were 
outside the lower and upper reference limits provided by 
the manufacturers of  the machine used (Table 2). The 
proportions of  out-of-range values ranged from 1.0% 
(1/105) to 88.6% (93/105). The majority of  out-of-range 
results for Hb concentration and absolute counts of  
neutrophils, eosinophils and basophils were below the lower 
reference limits. In contrast, the majority of  out-of-range 
results for platelet and monocyte counts were above the 
upper reference limits.
Classification of severity of out-of-range 
haematological results
Classification of  out-of-range values for six of  the 
haematological variables was done using the DAIDS grading 
criteria.20 As shown in Table 3, based on these criteria, up to 
55.0% (58/105) of  our otherwise healthy study participants 
would have erroneously been considered to have at least one 
grade 1-4 haematological adverse event (AE). Some of  the 
abnormal values for Hb concentration, neutrophil count, and 
platelets were classified as grade 3 (severe) or 4 (potentially 
life-threatening). 
Table 2: Analysis of haematological parameters for enrolled study 
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The aetiology of  “abnormal” haematological parameters 
in African populations remains largely unknown. In our 
study, males had statistically significantly higher WBC and 
basophil counts than females (notably, the sample size 
for females was much smaller than the male sample size). 
However, we did not find significant associations between 
haematological parameters and other selected demographic 
and anthropometric characteristics of  the study participants 
(ethnicity, age, and BMI); this could have been as a result of  
our limited sample size, especially the number of  females. 
Also, the BMI and age ranges in our study were narrow, and 
these minimal anthropometric and demographic differences 
likely contributed greatly to the minimal haematologic 
differences found among study participants. Most of  the 
participants had normal BMIs (20-25 kg/m2) and were 
fairly young adults (age range 19-35 years). Furthermore, 
we did not collect data on dietary and environmental factors 
that could affect the haematological parameters, and we 
did not repeat the tests to ensure accuracy. In general, the 
main limitation of  our study was the small sample size. The 
targeted sample size of  60 males and 60 females was not 
reached. Even if  these quotas were achieved, they only would 
have represented 50% of  the recommended sample size and 
this likely resulted some loss of  validity of  the study results. 
Nevertheless, this study works as a proof-of-concept study 
that can be used to design a more detailed study involving 
a wide range of  age and ethnic subpopulations in order to 
establish Malawian reference ranges. 
Previously, some investigators have suggested that the 
eosinophilia seen in healthy African subjects results from 
helminthic infection while anaemia could be because of  poor 
dietary intake of  micronutrients, such as iron and folic acid.23 
Research indicates that total WBC and neutrophil counts are 
lower among individuals of  African descent because of  the 
common African-derived ‘‘null’’ variant (rs2814778) of  the 
Duffy antigen receptor for chemokines (DARC) gene.24-26 It 
has been shown that by stopping the expression of  DARC 
on RBCs, the Duffy null variant may alter the concentration 
and distribution of  chemokines in the blood and tissue,27-30 
thus regulating neutrophil production and migration. This 
could be another reason for the low WBC counts among 
the apparently normal Malawian blood donors. This 
might confirm that some of  the apparent haematological 
abnormalities could simply result from normal genetic 
variations across different populations.3,5 The combination 
of  factors that may affect haematological outcomes may 
vary by location; studies are, therefore, needed to identify key 
factors affecting haematological outcomes and to generate 
specific local haematological reference ranges in different 
countries and regions. These outcomes highlight the need 
for a more detailed and robust local study to determine 
reference ranges for the various haematological variables.
Despite the limitations of  this study, some important 
measures, including those overlooked in other African 
studies,8,17 were seriously taken into consideration. Firstly, our 
study had a fair representation of  the Malawian population 
because of  our eligibility criteria, which excluded subjects with 
potential risk factors for abnormal haematologic parameters. 
Secondly, the haematological assays were performed at an 
internationally reputable laboratory with a good level of  
adherence to Clinical and Laboratory Standards Institute 
(CLSI) and Good Clinical Laboratory Practice (GCLP) 
standards. Thus, our findings are likely to be applicable to a 
healthy population of  Blantyre.
Findings of  this study suggest the need to conduct quality 
studies establishing local reference ranges for haematological 
variables in countries like Malawi. Such studies should 
collect data on key behavioural, dietary, and environmental 
factors that may affect haematological variables. In addition, 
the studies should prospectively monitor individuals with 
abnormal results to determine any abnormal clinical 
outcomes associated with the laboratory abnormalities. 
Furthermore, it would be necessary to conduct robust 
immunological tests for individuals with abnormal cell subset 
white cell counts, so as to establish their cause. Besides 
this, in clinical practice, abnormal haematological results 
should be repeated and reconciled with the patient’s clinical 
condition to avoid unnecessary and expensive treatment of  
otherwise healthy individuals. As is the case with our results; 
if  such “abnormal” results were detected in a clinical setting, 
a person who does not need treatment would have been 
treated because of  the use of  inappropriate reference values. 
We recommend that future studies should follow-up patients 
with mild and moderate abnormalities in order to assess 
potential short- and long-term clinical consequences of  
the abnormalities. It would be necessary, as well, to use two 
different analyzers for testing and to perform reproducibility 
studies on each analyzer. It would also be important to use 
statistical methodologies that could ensure that the reference 
ranges generated would clearly distinguish pathology from 
normal variation, while being a true reflection of  the normal 
Malawian. For instance, the skewed distribution of  our data 
may imply the inclusion of  participants with subclinical 
pathologies. Future studies should conduct additional tests, 
such as for markers of  inflammation (C-reactive protein, for 
example), to detect underlying pathologies.
In conclusion, data from this study showed that values of  
haematological variables for a significant number of  otherwise 
normal Malawians were outside a standard haematological 
machine’s reference limits, thereby suggesting abnormalities. 
This finding is consistent with results from other studies 
done in some African countries.
Table 3: Frequency and severity of abnormal values for study participants 




	 	 	 Grade	1	 Grade	2	 Grade	3	 Grade	4	
	 n	 %	 n	 %	 n	 %	 n	 %	 N	 %	
Leucopenia	 21	 20.0	 18	 85.7	 3	 14.3	 0	 0	 0	 0	
Anaemia	 62	 59.0	 48	 77.4	 12	 19.4	 2	 3.2	 0	 0	
Thrombocytopenia	 18	 17.1	 7	 38.9	 6	 33.3	 4	 22.2	 1	 5.6	
Neutropenia	 18	 17.1	 24	 48.0	 22	 44.0	 4	 8.0	 0	 0	
Lymphopenia	 1	 0.95	 0	 0	 0	 0	 0	 0	 0	 0	
Eosinophilia	 9	 8.6	 7	 77.8	 2	 22.2	 0	 0	 0	 0	
Leucopenia (x 109 cells/L): Grade 1 = 2.5-3.5, Grade 2 = 1.5-2.4, Grade 3 =1.0-1.4, Grade 4 < 1.0 
Anaemia (g/dL): Grade 1 = 12.5-14.5, Grade 2 = 10.5-12.4, Grade 3 = 8.5-10.4, Grade 4 < 8.5 
Thrombocytopenia (x 109 cells/L): Grade 1 = 125-140, Grade 2 = 100-124, Grade 3 = 25-99, Grade 4 < 25 
Neutropenia (x 109 cells/L): Grade 1 = 1.5-2.0, Grade 2 = 1.0-1.5, Grade 3 = 0.5-0.9, Grade 4 < 0.5 
Lymphopenia (x 109 cells/L): Grade 1 = 0.8-0.1-0, Grade 2 = 0.5-0.7, Grade 3 = 0.3-0.5, Grade 4 < 0.3 
Eosinophilia (x 109 cells/L): Grade 1 = 0.7-1.5, Grade 2 > 1.5, Grade 4 = hypereosinophilic syndrome 
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